BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Christos Svoronos, Georgios Tsoulfas, Maria Souvatzi, Efthimios Chatzitheoklitos. Prognostic value of COL6A3 in pancreatic adenocarcinomaAnnals of Hepato-Biliary-Pancreatic Surgery 2020; 24(1): 52 doi: 10.14701/ahbps.2020.24.1.52
2
Jennifer L. Pretz, Michael A. Blake, Joseph H. Killoran, Harvey J. Mamon, Jennifer Y. Wo, Andrew X. Zhu, Theodore S. Hong. Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancerPractical Radiation Oncology 2018; 8(3): 179 doi: 10.1016/j.prro.2017.09.008
3
Bolun Jiang, Li Zhou, Jun Lu, Yizhi Wang, Chengxi Liu, Lei You, Junchao Guo. Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.576399
4
Jun Zhao, Huamin Wang, Cheng-Hui Hsiao, Diana S.-L. Chow, Eugene J. Koay, Yaan Kang, Xiaoxia Wen, Qian Huang, Ying Ma, James A. Bankson, Stephen E. Ullrich, Willem Overwijk, Anirban Maitra, David Piwnica-Worms, Jason B. Fleming, Chun Li. Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapyBiomaterials 2018; 159: 215 doi: 10.1016/j.biomaterials.2018.01.014
5
Neus Martínez-Bosch, Pedro Enrique Guerrero, Mireia Moreno, Anabel José, Mar Iglesias, Jessica Munné-Collado, Héctor Anta, Joan Gibert, Carlos Alberto Orozco, Judith Vinaixa, Cristina Fillat, Francesc Viñals, Pilar Navarro. The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancerOncotarget 2016; 7(30): 48265 doi: 10.18632/oncotarget.10199
6
Tian-Jiao Li, Wen-Quan Wang, Xian-Jun Yu, Liang Liu. Killing the “BAD”: Challenges for immunotherapy in pancreatic cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(1): 188384 doi: 10.1016/j.bbcan.2020.188384
7
David J. Birnbaum, François Bertucci, Pascal Finetti, Daniel Birnbaum, Emilie Mamessier. Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2018; 1869(2): 248 doi: 10.1016/j.bbcan.2018.02.001
8
Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Maki Okada, Mitsuru Koizumi, Hirokazu Satoh, Gene Kurosawa, Yoshikazu Kurosawa, Tsuneo Saga, C Andrew Boswell. Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse ModelsPLOS ONE 2015; 10(4): e0123761 doi: 10.1371/journal.pone.0123761
9
Yuanke Li, Zhen Zhao, Hao Liu, John Peter Fetse, Akshay Jain, Chien-Yu Lin, Kun Cheng. Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and StromaACS Applied Materials & Interfaces 2019; 11(49): 45390 doi: 10.1021/acsami.9b15116
10
Tasuku Matsuoka, Masakazu Yashiro. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studiesWorld Journal of Gastroenterology 2016; 22(2): 776-789 doi: 10.3748/wjg.v22.i2.776
11
Emma Eriksson, Ioanna Milenova, Jessica Wenthe, Rafael Moreno, Ramon Alemany, Angelica Loskog. IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1The Journal of Immunology 2019; 202(3): 787 doi: 10.4049/jimmunol.1800717
12
Richard A. Skelton, Ammar Javed, Lei Zheng, Jin He. Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitorsJournal of Surgical Oncology 2017; 116(1): 55 doi: 10.1002/jso.24642
13
Charles Pottier, Alodie Wheatherspoon, Patrick Roncarati, Rémi Longuespée, Michael Herfs, Anaelle Duray, Philippe Delvenne, Pascale Quatresooz. The importance of the tumor microenvironment in the therapeutic management of cancerExpert Review of Anticancer Therapy 2015; 15(8): 943 doi: 10.1586/14737140.2015.1059279
14
Zhengsheng Liu, Ling Zhang, Zhou Tian, Chao Kong, Chun Liu, Huiqin Liu, Fang Yuan, Weijian Kong, Feng Qian. Paclitaxel and Itraconazole Co‐Encapsulated Micelle Prolongs the Survival of Spontaneous LSL‐Kras G12D/+ , LSL‐Trp53 R172H/+ , Pdx‐1‐Cre Genetically Engineered Mouse Model of Pancreatic Cancer Advanced Therapeutics 2019; 2(9): 1900032 doi: 10.1002/adtp.201900032
15
Jian Xu, Youting Chen, Hong Chen, Zhipeng Hong, Zheng Shi, Shuangmu Zhuo, Xiaoqin Zhu, Jianxin Chen. Identifying the neck margin status of ductal adenocarcinoma in the pancreatic head by multiphoton microscopyScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04771-w
16
Solange Moll, Matthias Meier, Ivan Formentini, Silvia Pomposiello, Marco Prunotto. New renal drug development to face chronic renal diseaseExpert Opinion on Drug Discovery 2014; 9(12): 1471 doi: 10.1517/17460441.2014.956075
17
Han-xiang Zhan, Bin Zhou, Yu-gang Cheng, Jian-wei Xu, Lei Wang, Guang-yong Zhang, San-yuan Hu. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biologyCancer Letters 2017; 392: 83 doi: 10.1016/j.canlet.2017.01.041
18
Demi S. Houg, Maarten F. Bijlsma. The hepatic pre-metastatic niche in pancreatic ductal adenocarcinomaMolecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0842-9
19
Wenxi Zhou, Yu Zhou, Xinli Chen, Tingting Ning, Hongyi Chen, Qin Guo, Yiwen Zhang, Peixin Liu, Yujie Zhang, Chao Li, Yongchao Chu, Tao Sun, Chen Jiang, Supporting Information. Pancreatic Cancer-Targeting Exosomes for Enhancing Immunotherapy and Reprogramming Tumor MicroenvironmentBiomaterials 2020; : 120546 doi: 10.1016/j.biomaterials.2020.120546
20
Isabel Mejia, Sandhya Bodapati, Kathryn T. Chen, Begoña Díaz. Pancreatic Adenocarcinoma Invasiveness and the Tumor Microenvironment: From Biology to Clinical TrialsBiomedicines 2020; 8(10): 401 doi: 10.3390/biomedicines8100401
21
Reinhild Holmer, Freya A Goumas, Georg H Waetzig, Stefan Rose-John, Holger Kalthoff. Interleukin-6: a villain in the drama of pancreatic cancer development and progressionHepatobiliary & Pancreatic Diseases International 2014; 13(4): 371 doi: 10.1016/S1499-3872(14)60259-9
22
Rosella Spadi, Federica Brusa, Agostino Ponzetti, Isabella Chiappino, Nadia Birocco, Libero Ciuffreda, Maria Antonietta Satolli. Current therapeutic strategies for advanced pancreatic cancer: A review for cliniciansWorld Journal of Clinical Oncology 2016; 7(1): 27-43 doi: 10.5306/wjco.v7.i1.27
23
Petr Busek, Zdislava Vanickova, Petr Hrabal, Marek Brabec, Premysl Fric, Miroslav Zavoral, Jan Skrha, Klara Kmochova, Martin Laclav, Bohus Bunganic, Koen Augustyns, Pieter Van Der Veken, Aleksi Sedo. Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinomaPancreatology 2016; 16(5): 829 doi: 10.1016/j.pan.2016.06.001
24
Afsane Bahrami, Majid Khazaei, Fariba Bagherieh, Majid Ghayour-Mobarhan, Mina Maftouh, Seyed Mahdi Hassanian, Amir Avan. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapiesJournal of Cellular Physiology 2017; 232(11): 2931 doi: 10.1002/jcp.25798
25
Masanori Tsujie, Soichi Fumita, Tomoko Wakasa, Shigeto Mizuno, Hajime Ishikawa, Kotaro Kitani, Shumpei Satoi, Kaoru Okada, Keisuke Inoue, Shuichi Fukuda, Hironobu Manabe, Noriko Ichimura, Shinya Ueda, Takao Tamura, Toshihiko Kawasaki, Masao Yukawa, Yoshio Ohta, Masatoshi Inoue. A Case of Pathological Complete Response Following FOLFIRINOX Therapy for Pancreatic Adenocarcinoma with Synchronous Distant Lymph Node MetastasesInternational Journal of Surgery Case Reports 2020; 72: 471 doi: 10.1016/j.ijscr.2020.06.044
26
Kelly Foley, Victoria Kim, Elizabeth Jaffee, Lei Zheng. Current progress in immunotherapy for pancreatic cancerCancer Letters 2016; 381(1): 244 doi: 10.1016/j.canlet.2015.12.020
27
Dingyuan Hu, Daniel Ansari, Krzysztof Pawłowski, Qimin Zhou, Agata Sasor, Charlotte Welinder, Theresa Kristl, Monika Bauden, Melinda Rezeli, Yi Jiang, György Marko-Varga, Roland Andersson. Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinomaOncotarget 2018; 9(11): 9789 doi: 10.18632/oncotarget.23929
28
Satoshi Sakai, Caname Iwata, Hiroyoshi Y. Tanaka, Horacio Cabral, Yasuyuki Morishita, Kohei Miyazono, Mitsunobu R. Kano. Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2Journal of Controlled Release 2016; 230: 109 doi: 10.1016/j.jconrel.2016.04.007
29
Michael Friberg Bruun Nielsen, Michael Bau Mortensen, Sönke Detlefsen. Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cellsWorld Journal of Gastroenterology 2016; 22(9): 2678-2700 doi: 10.3748/wjg.v22.i9.2678
30
Sreenivasa Chandana, Hani M. Babiker, Daruka Mahadevan. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)Expert Opinion on Investigational Drugs 2019; 28(2): 161 doi: 10.1080/13543784.2019.1557145
31
Fabio Grizzi, Sirio Fiorino, Dorina Qehajaj, Adele Fornelli, Carlo Russo, Dario de Biase, Michele Masetti, Laura Mastrangelo, Matteo Zanello, Raffaele Lombardi, Andrea Domanico, Esterita Accogli, Andrea Tura, Leonardo Mirandola, Maurizio Chiriva-Internati, Robert S. Bresalier, Elio Jovine, Paolo Leandri, Luca Di Tommaso. Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot studyJournal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1817-3
32
Meng-wen Zhang, Kenji Fujiwara, Xu Che, Shu Zheng, Lei Zheng. DNA methylation in the tumor microenvironmentJournal of Zhejiang University-SCIENCE B 2017; 18(5): 365 doi: 10.1631/jzus.B1600579
33
Pavan P. Adiseshaiah, Rachael M. Crist, Sara S. Hook, Scott E. McNeil. Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancerNature Reviews Clinical Oncology 2016; 13(12): 750 doi: 10.1038/nrclinonc.2016.119
34
Yu Yu, Jiuwei Cui. Present and future of cancer immunotherapy: A tumor microenvironmental perspective (Review)Oncology Letters 2018;  doi: 10.3892/ol.2018.9219
35
Manoj K. Bhasin, Kenneth Ndebele, Octavian Bucur, Eric U. Yee, Hasan H. Otu, Jessica Plati, Andrea Bullock, Xuesong Gu, Eduardo Castan, Peng Zhang, Robert Najarian, Maria S. Muraru, Rebecca Miksad, Roya Khosravi-Far, Towia A. Libermann. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifierOncotarget 2016; 7(17): 23263 doi: 10.18632/oncotarget.8139
36
Kedar Deodhar. PET/CT in Hepatobiliary and Pancreatic Malignancies2018; : 13 doi: 10.1007/978-3-319-60507-4_2
37
Giulia Brachi, Federico Bussolino, Gianluca Ciardelli, Clara Mattu. Nanomedicine for Imaging and Therapy of Pancreatic AdenocarcinomaFrontiers in Bioengineering and Biotechnology 2019; 7 doi: 10.3389/fbioe.2019.00307
38
Shannon M. Gallagher‐Colombo, Jarod C. Finlay, Theresa M. Busch. Resistance to Photodynamic Therapy in CancerResistance to Targeted Anti-Cancer Therapeutics 2015; 5: 65 doi: 10.1007/978-3-319-12730-9_3
39
Anteneh A. Tesfaye, Mandana Kamgar, Asfar Azmi, Philip A. Philip. The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunitiesExpert Review of Anticancer Therapy 2018; 18(2): 131 doi: 10.1080/14737140.2018.1417844
40
Noelle R. Jurcak, Agnieszka A. Rucki, Stephen Muth, Elizabeth Thompson, Rajni Sharma, Ding Ding, Qingfeng Zhu, James R. Eshleman, Robert A. Anders, Elizabeth M. Jaffee, Kenji Fujiwara, Lei Zheng. Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in MiceGastroenterology 2019; 157(3): 838 doi: 10.1053/j.gastro.2019.05.065
41
Claudia Minici, Elena Rigamonti, Marco Lanzillotta, Antonella Monno, Lucrezia Rovati, Takashi Maehara, Naoki Kaneko, Vikram Deshpande, Maria Pia Protti, Lucia De Monte, Cristina Scielzo, Stefano Crippa, Paolo Giorgio Arcidiacono, Erica Dugnani, Lorenzo Piemonti, Massimo Falconi, Shiv Pillai, Angelo A. Manfredi, Emanuel Della-Torre. B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinomaOncoImmunology 2020; 9(1): 1794359 doi: 10.1080/2162402X.2020.1794359
42
Boju Pan, Quan Liao, Zheyu Niu, Li Zhou, Yupei Zhao. Cancer-associated fibroblasts in pancreatic adenocarcinomaFuture Oncology 2015; 11(18): 2603 doi: 10.2217/fon.15.176
43
Laura Witteck, Robert Jaster. Trametinib and dactolisib but not regorafenib exert antiproliferative effects on rat pancreatic stellate cellsHepatobiliary & Pancreatic Diseases International 2015; 14(6): 642 doi: 10.1016/S1499-3872(15)60032-7
44
Carina Strell, Karin Jessica Norberg, Artur Mezheyeuski, Jonas Schnittert, Praneeth R Kuninty, Carlos Fernández Moro, Janna Paulsson, Nicolai Aagaard Schultz, Dan Calatayud, Johannes Matthias Löhr, Oliver Frings, Caroline Sophie Verbeke, Rainer Lothar Heuchel, Jai Prakash, Julia Sidenius Johansen, Arne Östman. Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AACBritish Journal of Cancer 2017; 117(1): 65 doi: 10.1038/bjc.2017.140
45
Maeve A. Lowery, Eileen M. O'Reilly. Novel Therapeutics for Pancreatic AdenocarcinomaHematology/Oncology Clinics of North America 2015; 29(4): 777 doi: 10.1016/j.hoc.2015.04.006
46
Awalpreet S. Chadha, Allison Khoo, Maureen L. Aliru, Harpreet K. Arora, Jillian R. Gunther, Sunil Krishnan. Recent Advances and Prospects for Multimodality Therapy in Pancreatic CancerSeminars in Radiation Oncology 2016; 26(4): 320 doi: 10.1016/j.semradonc.2016.05.002
47
Laleh G. Melstrom, Marcela D. Salazar, Don J. Diamond. The pancreatic cancer microenvironment: A true double agentJournal of Surgical Oncology 2017; 116(1): 7 doi: 10.1002/jso.24643
48
Mariana Monteiro Val, Luís André Mendes, Ana Alarcão, Lina Carvalho, Isabel Carreira, Carlos Fernando D. Rodrigues, Maria Carmen Alpoim. Senescent bronchial fibroblasts induced to senescence by Cr(VI) promote epithelial–mesenchymal transition when co-cultured with bronchial epithelial cells in the presence of Cr(VI)Mutagenesis 2015; 30(2): 277 doi: 10.1093/mutage/geu070
49
Ahmad R. Cheema, Eileen M. O’Reilly. Management of Metastatic Pancreatic AdenocarcinomaSurgical Clinics of North America 2016; 96(6): 1391 doi: 10.1016/j.suc.2016.07.011
50
Hiroyoshi Y. Tanaka, Kentaro Kitahara, Naoki Sasaki, Natsumi Nakao, Kae Sato, Hirokazu Narita, Hiroshi Shimoda, Michiya Matsusaki, Hiroshi Nishihara, Atsushi Masamune, Mitsunobu R. Kano. Pancreatic stellate cells derived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECM remodeling in 3D engineered fibrotic tissue of clinically relevant thicknessBiomaterials 2019; 192: 355 doi: 10.1016/j.biomaterials.2018.11.023
51
Betty Laverdet, Dorothée Girard, Alexis Desmoulière. Physiologie de la peau, réparation cutanée et réaction stromaleActualités Pharmaceutiques 2018; 57(581): 20 doi: 10.1016/j.actpha.2018.10.004
52
Somala Mohammed, Sujita Sukumaran, Pradip Bajgain, Norihiro Watanabe, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, William E. Fisher, Ann M. Leen, Juan F. Vera. Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic CancerMolecular Therapy 2017; 25(1): 249 doi: 10.1016/j.ymthe.2016.10.016
53
Janaiah Kota, Julie Hancock, Jason Kwon, Murray Korc. Pancreatic cancer: Stroma and its current and emerging targeted therapiesCancer Letters 2017; 391: 38 doi: 10.1016/j.canlet.2016.12.035